RALA and exocrine pancreatic carcinoma: RAL proteins are usually found to be highly activated in pancreatic carcinoma cell lines, which are very frequently driven by K-RAS mutations (13, 20) and the activated RAL “transcription fingerprint” correlates with reduced survival in cancer (29).